Proto Labs, Inc.
PRLB
$50.86
$0.080.16%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 135.37M | 135.06M | 126.21M | 121.75M | 125.62M |
| Total Other Revenue | -- | -- | -- | -- | 281.00K |
| Total Revenue | 135.37M | 135.06M | 126.21M | 121.75M | 125.62M |
| Cost of Revenue | 74.07M | 75.29M | 70.51M | 69.79M | 68.39M |
| Gross Profit | 61.29M | 59.77M | 55.70M | 51.96M | 57.23M |
| SG&A Expenses | 41.74M | 43.48M | 40.60M | 38.17M | 38.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 126.52M | 129.95M | 121.71M | 117.66M | 117.04M |
| Operating Income | 8.85M | 5.12M | 4.49M | 4.09M | 8.58M |
| Income Before Tax | 10.25M | 6.67M | 5.99M | -282.00K | 9.87M |
| Income Tax Expenses | 3.04M | 2.25M | 2.39M | 122.00K | 2.68M |
| Earnings from Continuing Operations | 7.22M | 4.43M | 3.60M | -404.00K | 7.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.22M | 4.43M | 3.60M | -404.00K | 7.19M |
| EBIT | 8.85M | 5.12M | 4.49M | 4.09M | 8.58M |
| EBITDA | 17.28M | 13.69M | 13.19M | 13.24M | 17.49M |
| EPS Basic | 0.30 | 0.19 | 0.15 | -0.02 | 0.29 |
| Normalized Basic EPS | 0.27 | 0.18 | 0.15 | 0.14 | 0.25 |
| EPS Diluted | 0.30 | 0.18 | 0.15 | -0.02 | 0.29 |
| Normalized Diluted EPS | 0.27 | 0.18 | 0.15 | 0.14 | 0.25 |
| Average Basic Shares Outstanding | 23.89M | 23.90M | 24.14M | 24.47M | 24.98M |
| Average Diluted Shares Outstanding | 24.19M | 24.10M | 24.44M | 24.47M | 25.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |